• Latest News

    Latest News

OptiMed Specialty Pharmacy and Captify Health Launch Innovative Patient Management Solution to Reduce Healthcare Costs After Surgery

KALAMAZOO, MICHIGAN – With approximately 30 million operations being performed annually in the United States, OptiMed Specialty Pharmacy, dedicated to delivering excellence and value in healthcare, and Captify Health, a provider of patient education and adherence services, have teamed together to launch a new, revolutionary patient program that aims to lessen complications, improve outcomes and reduce hospitalization costs after surgery.

Continue Reading

OptiMed Specialty Pharmacy to Distribute Cosentyx

KALAMAZOO, MI--(Marketwired - April 23, 2016) - OptiMed Specialty Pharmacy has been selected to dispense the limited distribution drug Cosentyx (secukinumab) manufactured by Novartis Pharmaceutical. Cosentyx is a biologic product that is FDA approved to treat adults with any of the following autoimmune inflammatory disorders: moderate to severe plaque psoriasis, active psoriatic arthritis, or active ankylosing spondylitis.

Continue Reading

OptiMed Featured in Specialty Pharmacy Times

IN AN ERA OF ESCLATING HEALTH CARE COSTS AND INCREASING DRUG COMPLEXITIES, OptiMed Specialty Pharmacy aims to help patients, providers and stakeholders navigate the intricacies of specialty medication therapy, while keeping patient outcomes at the forefront. OptiMed is able to deliver exceptional patient care services backed by a strong clinical foundation and a commitment to quality throughout the entire organization, as demonstrated by their dual accreditation from URAC and ACHC. OptiMed takes a value-driven approach to specialty patient management. With an increasing national presence, OptiMed is well-poised to leave a positive footprint on the specialty pharmacy market.

Continue Reading

  • 1
  • 2

“OptiMed is pro-active – they know what I need before I do!”

Auto-Immune Patient